Business Context and Reporting Period
Company: Horizon Technology Finance Corp (HRZN)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2019
Business Overview: An externally managed, closed-end, non-diversified business development company (BDC) and regulated investment company (RIC). The company primarily makes secured debt investments (venture loans) to development-stage companies in technology, life science, healthcare information and services, and cleantech industries.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2019 | Six Months Ended June 30, 2018 |
|---|---|---|
| Total Investment Income | $18.8 million | $14.5 million |
| Net Investment Income | $8.2 million | $6.5 million |
| Net Increase in Net Assets from Operations | $7.6 million | $5.5 million |
| Net Realized Loss on Investments | ($3.4 million) | ($0.3 million) |
| Net Unrealized Appreciation | $2.8 million | ($0.7 million) |
| Total Assets | $289.3 million | $266.7 million |
| Total Borrowings (Net) | $125.5 million | $126.9 million |
| Cash and Cash Equivalents | $7.6 million | $12.6 million |
| Net Asset Value (NAV) per Share | $11.60 | $11.64 |
| Distributions Declared per Share | $0.60 | $0.60 |
Material Changes vs. Prior Period
- Investment Income Growth: Total investment income increased 29.6% year-over-year, driven by a 17.2% increase in the average size of the debt investment portfolio and higher LIBOR rates.
- Expense Increases: Net expenses rose 31.8% to $10.5 million. Interest expense increased 41.8% due to higher average borrowings and LIBOR rates. Base management fees increased 20.9% due to a larger asset base.
- Fee Waivers: The Advisor waived $1.8 million of performance-based incentive fees for the six months ended June 30, 2019, compared to $0.2 million in the prior year period. This waiver significantly reduced net expenses.
- Realized Losses: Net realized losses increased to $3.4 million, primarily due to the expiration of a royalty agreement, partially offset by gains on equity sales and warrant terminations.
- Portfolio Expansion: The company completed a follow-on public offering in March 2019, raising $23.1 million in net proceeds, and increased new debt investments to $93.1 million for the six-month period.
Guidance, Outlook, and Risks
- Capital Raising: The company raised $23.1 million via a follow-on offering of 2 million shares in March 2019. It maintains a stock repurchase program authorizing up to $5.0 million, though no repurchases were made in the period.
- Liquidity: As of June 30, 2019, the company had $7.6 million in cash and $36.0 million in unused commitment capacity under its Key Facility (revolving credit line). Management believes current resources are sufficient for the next 12 months.
- Asset Coverage: The company operates under a 150% asset coverage requirement (reduced from 200% following stockholder approval in October 2018). Asset coverage was 224% as of June 30, 2019.
- Interest Rate Risk: Approximately 99% of debt investments bear floating interest rates. A 100 basis point increase in rates would increase net assets by approximately $1.6 million annually, while a decrease would reduce them by $0.96 million.
- Credit Quality: One debt investment (Audacy Corporation) was placed on non-accrual status with a fair value of $1.5 million. The weighted average credit rating of the portfolio was 3.1.
Investor Verification Checklist
- Fee Waiver Sustainability: Verify if the $1.8 million incentive fee waiver is a one-time event or indicative of future fee structures, as it materially impacts net investment income.
- Non-Accrual Status: Monitor the status of the Audacy Corporation loan (non-accrual) and potential impact on future realized losses.
- Portfolio Concentration: Review the top five debt investments, which represented 29% of the total debt portfolio at cost.
- Unfunded Commitments: Assess the $43.0 million in unfunded commitments and the company's ability to fund them given current cash and borrowing capacity.
- NAV vs. Market Price: Compare the reported NAV of $11.60 per share against the market trading price to evaluate the discount/premium.